Ain Holdings Inc. (TYO:9627)
6,140.00
-19.00 (-0.31%)
Aug 21, 2026, 3:30 PM JST
Ain Holdings Revenue
In the fiscal year ending April 30, 2026, Ain Holdings had annual revenue of 647.83B JPY with 41.82% growth. Ain Holdings had revenue of 172.95B in the quarter ending April 30, 2026, with 44.16% growth.
Revenue
647.83B
Revenue Growth
+41.82%
P/S Ratio
0.33
Revenue / Employee
37.38M
Employees
17,332
Market Cap
215.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 647.83B | 191.03B | 41.82% |
| Apr 30, 2025 | 456.80B | 56.98B | 14.25% |
| Apr 30, 2024 | 399.82B | 41.08B | 11.45% |
| Apr 30, 2023 | 358.74B | 42.50B | 13.44% |
| Apr 30, 2022 | 316.25B | 18.94B | 6.37% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tsuruha Holdings | 1.81T |
| MatsukiyoCocokara & Co. | 1.13T |
| COSMOS Pharmaceutical | 1.10T |
| Sugi Holdings | 1.04T |
| Sundrug | 850.15B |
| Kusuri No Aoki Holdings | 566.87B |
| Kyowa Kirin | 529.80B |
| Create SD Holdings | 497.13B |